drugset / Trial / NCT05084963
A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to asses the efficacy, safety and tolerability of repeat doses of IRL201104 in Adult Participants with Active Eosinophilic Esophagitis (EoE)
Timeline
- Start
- 2021-10-29
- Primary completion
- 2022-10-24
- Completion
- 2022-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IRL201104 | Protein / enzyme biologic | — | Intravenous |